Infliximab-Induced Acute Liver Failure in a Patient With Crohn's Disease Requiring Orthotopic Liver Transplantation

Tumor necrosis factor-alpha inhibitors are not known to have significant liver toxicity; however, a few case reports state otherwise. We report the case of a 25-year-old man with Crohn's disease who was initiated on infliximab. The patient developed severe mixed hepatocellular and cholestatic l...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa Alikhan, Muhammed, Mansoor, Emad, Satyavada, Sagarika, Greer, Katarina, Xin, Wei, Cohen, Stanley, Cooper, Gregory, Katz, Jeffry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126550/
https://www.ncbi.nlm.nih.gov/pubmed/34007859
http://dx.doi.org/10.14309/crj.0000000000000586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126550/
https://www.ncbi.nlm.nih.gov/pubmed/34007859
http://dx.doi.org/10.14309/crj.0000000000000586

Ejemplares similares